Israel-based medical imaging technology firm NANO-X IMAGING (Nanox) has secured $26m in funding to support the development, commercialisation and deployment of its Nanox System.

The $26m, which was secured with the participation of strategic investor Foxconn, brings the total funds raised for the project to $55m thus far. Fujifilm and SK Telecom have also previously invested in the endeavour.

The company’s founder and CEO Ran Poliakine said: “We are honoured to have Foxconn join other world leaders, Fujifilm and SK Telecom, in investing in our vision of eradicating cancer.

“Nanox has achieved a technological breakthrough by digitizing traditional X-rays. Now we are ready to take a giant leap forward in making it possible to provide one scan per person, per year, for preventative measures.”

The imaging service will include an image repository, radiologist matching, online and offline diagnostics review and annotation, connectivity to diagnostic assistive artificial intelligence (AI) systems, billing and reporting.

Nanox’s digital X-ray source technology, combined with its planned software solution, should enable it to build medical imaging systems at significantly lower costs than existing medical imaging systems. This could promote earlier detection of medical conditions discoverable by X-ray and X-ray based imaged like computed tomography, mammography, fluoroscopy and angiogram.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The availability of a lower cost device has the potential to expand medical imaging availability and improve the accessibility of early-detection services across the globe. Nanox plans to offer a pay-per-scan business model at a lower price than current alternatives.

Following regulatory approval, Nanox plans to work with governments, hospitals and clinic chains to deploy its technology.